# A Multidisciplinary Approach to Silent Ischaemic Strokes Unveiling Primary CNS Vasculitis: Exploring Beyond the Apparent

**Authors:** Syed Muhammad Meeran Hussain, Anum Faisal

PMC · DOI: 10.7759/cureus.94547 · 2025-10-14

## TL;DR

A 42-year-old woman with unexplained silent strokes was diagnosed with primary CNS vasculitis through a multidisciplinary approach, highlighting the need for early consideration of this condition in young patients.

## Contribution

The paper emphasizes the importance of a multidisciplinary approach in diagnosing primary CNS vasculitis in young patients with recurrent or silent ischaemic strokes.

## Key findings

- The patient's diagnosis of primary CNS vasculitis was based on neuroimaging and CSF findings despite negative autoimmune screens.
- Multidisciplinary evaluation involving stroke, neuroradiology, and rheumatology was crucial for timely diagnosis.
- The patient responded to treatment with intravenous methylprednisolone and methotrexate.

## Abstract

Diagnosing first-episode strokes due to central nervous system (CNS) vasculitis is challenging, particularly when systemic vasculitis features are absent. We present the case of a 42-year-old female patient with hypertension, type 2 diabetes mellitus, and a psychiatric history, who presented with confusion and sleep disturbances. Initial CT brain revealed multiple hypodense foci suggestive of vascular insult, and MRI demonstrated multiple ischaemic infarcts in the right middle cerebral artery (MCA) territory, with features raising suspicion for medium-vessel vasculitis. Despite dual antiplatelet therapy (DAPT), she experienced further silent infarcts in the left MCA territory. A multidisciplinary evaluation, including stroke, neuroradiology, and rheumatology specialists, led to a diagnosis of CNS vasculitis based on neuroimaging findings, elevated cerebrospinal fluid (CSF) protein, negative autoimmune screen, and normal complement levels. She received intravenous methylprednisolone followed by oral prednisolone and methotrexate. Primary CNS vasculitis (PCNSV) should be considered in young patients with unexplained recurrent or silent ischaemic strokes, and a multidisciplinary approach is essential for timely diagnosis and management.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741), prednisolone (PubChem CID 5755), methotrexate (PubChem CID 4112)
- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), primary CNS vasculitis (MONDO:0015374), central nervous system vasculitis (MONDO:0003346)

## Full-text entities

- **Diseases:** Ischaemic Strokes (MESH:D002544), CNS vasculitis (MESH:D020293), psychiatric (MESH:D001523), autoimmune (MESH:D001327), confusion (MESH:D003221), type 2 diabetes mellitus (MESH:D003924), hypertension (MESH:D006973), systemic vasculitis (MESH:D056647), sleep disturbances (MESH:D012893), stroke (MESH:D020521), infarcts (MESH:D007238), medium-vessel vasculitis (MESH:D014657)
- **Chemicals:** methylprednisolone (MESH:D008775), methotrexate (MESH:D008727), prednisolone (MESH:D011239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12615988/full.md

---
Source: https://tomesphere.com/paper/PMC12615988